ES2046889T3 - Metodo para inhibicion de la maduracion folicular. - Google Patents

Metodo para inhibicion de la maduracion folicular.

Info

Publication number
ES2046889T3
ES2046889T3 ES199191902826T ES91902826T ES2046889T3 ES 2046889 T3 ES2046889 T3 ES 2046889T3 ES 199191902826 T ES199191902826 T ES 199191902826T ES 91902826 T ES91902826 T ES 91902826T ES 2046889 T3 ES2046889 T3 ES 2046889T3
Authority
ES
Spain
Prior art keywords
maturation
folicular
inhibition
ovary
polystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES199191902826T
Other languages
English (en)
Inventor
Teresa K. Woodruff
Jennie P. Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2046889T3 publication Critical patent/ES2046889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manipulator (AREA)

Abstract

SE PRESENTA UN METODO PARA INHIBIR LA MADURACION DE LOS FOLICULOS EN EL OVARIO DE UN MAMIFERO HEMBRA; EL METODO COMPRENDE LA ADMINISTRACION AL OVARIO DEL MAMIFERO DE UNA CANTIDAD EFECTIVA DE ACTIVINA. ESTE METODO ES PARTICULARMENTE EFECTIVO PARA EL TRATAMIENTO DE LA ENFERMEDAD POLICISTICA DEL OVARIO.
ES199191902826T 1990-01-08 1991-01-04 Metodo para inhibicion de la maduracion folicular. Expired - Lifetime ES2046889T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/461,705 US5102868A (en) 1990-01-08 1990-01-08 Method for inhibiting follicular maturation

Publications (1)

Publication Number Publication Date
ES2046889T3 true ES2046889T3 (es) 1994-02-01

Family

ID=23833619

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199191902826T Expired - Lifetime ES2046889T3 (es) 1990-01-08 1991-01-04 Metodo para inhibicion de la maduracion folicular.

Country Status (10)

Country Link
US (1) US5102868A (es)
EP (1) EP0509047B1 (es)
JP (1) JPH05503702A (es)
AT (1) ATE94405T1 (es)
AU (1) AU636195B2 (es)
CA (1) CA2069756A1 (es)
DE (1) DE69100376T2 (es)
DK (1) DK0509047T3 (es)
ES (1) ES2046889T3 (es)
WO (1) WO1991010446A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489288B1 (en) 1990-03-16 2002-12-03 Applied Research Systems Ars Holding Treatment of polycystic ovarian disease
EP0548276A4 (en) * 1990-09-13 1993-12-29 Children's Hospital Medical Center Of Northern California Method for increasing red blood cell production by treatment with activin or activin-related peptides
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5487895A (en) * 1993-08-13 1996-01-30 Vitaphore Corporation Method for forming controlled release polymeric substrate
WO1995005161A1 (en) * 1993-08-13 1995-02-23 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
GB2306481A (en) * 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
AU777166B2 (en) * 1999-12-15 2004-10-07 Research Development Foundation Betaglycan as an inhibin receptor and uses thereof
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence
WO2006020683A1 (en) * 2004-08-10 2006-02-23 Voyager Pharmaceutical Corporation Methods for treating premature infants
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
US7954505B2 (en) * 2007-12-03 2011-06-07 Matthew Odachowski Mobile leakage containment box including a liquid impermeable membrane
CN116948028B (zh) * 2023-09-20 2023-11-28 北京合源汇丰医药科技有限公司 一种抗抑制素抗体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein
US4764502A (en) * 1983-03-15 1988-08-16 University Of Southern California Intragonadal regulatory protein
US4912201A (en) * 1983-03-15 1990-03-27 University Of Southern California Monoclonal antibodies and antisera to intragonadal regulatory protein
CA1268417A (en) * 1984-10-11 1990-05-01 Gere S. Dizerega Intragonadal regulatory protein
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males

Also Published As

Publication number Publication date
DK0509047T3 (da) 1994-03-21
ATE94405T1 (de) 1993-10-15
JPH05503702A (ja) 1993-06-17
AU636195B2 (en) 1993-04-22
DE69100376D1 (de) 1993-10-21
DE69100376T2 (de) 1994-03-17
AU7078391A (en) 1991-08-05
WO1991010446A1 (en) 1991-07-25
EP0509047A1 (en) 1992-10-21
US5102868A (en) 1992-04-07
CA2069756A1 (en) 1991-07-09
EP0509047B1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
ES2046889T3 (es) Metodo para inhibicion de la maduracion folicular.
ES2052378T3 (es) Metodo para predisponer a los mamiferos a una reparacion acelerada de los tejidos.
ES2060362T3 (es) Metodo para aumentar la fertilidad en los machos.
ES2117646T3 (es) Alteracion de la velocidad y el caracter del crecimiento del pelo.
ES2174992T3 (es) Productos intermediarios para la obtencion de compuestos inhibidores de proteasas retrovirales.
ES2005572A6 (es) Un procedimiento para la preparacion de nuevos derivados del tetrahidronaftaleno
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
FI113619B (fi) Menetelmä injektoitavien taksaanijohdannaisiin pohjautuvien koostumusten valmistamiseksi
ES2067248T3 (es) Derivados de indol como agentes antialergicos y antiinflamatorios.
ES2114931T3 (es) Nuevos esteres esteroidales.
ES2071227T3 (es) Composicion para gotas para los ojos.
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
PE13197A1 (es) Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas
ES2068705T3 (es) Tratamiento de la enfermedad neoplastica con interleuquina-10.
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
NO924371L (es)
CO4230097A1 (es) Piridopirimidinas sustituidas como antihipertensivos
ES2133289T3 (es) Aumento en los niveles de glutation con glutamina.
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
ES481985A1 (es) Procedimiento para la obtencion de 14,15- metilenderivados de la serie de los estranos.
ES2107806T3 (es) Nuevos esteroides.
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
GR890300079T1 (en) Polycyclic aromatic compounds, process for their preparation and their use in human and animal medicine and in cosmetics

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509047

Country of ref document: ES